Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

Promise of AI in drug discovery: Exscientia raises $60m in Series C round

Novo Holdings led AI drug discovery-focused Exscientia’s recent $60m Series C round. In a strong vote of confidence, three previous investors - of which two are also development partners – of Exscientia also participated in the round.

Close
Close
Close

Go Top